GENE ONLINE|News &
Opinion
Blog

2022-04-21|

AACR 2022: Stand Up to Cancer, Standing up to Treatment

by Eduardo Longoria
Share To
At the AACR 2022 Annual Meeting, a session titled “Optimizing Cell-based Therapies for Clinical Impact,’ an open scientific session, was hosted by Raymond DuBois, the Dean of the College of Medicine at the Medical University of South Carolina. Researchers discussed advancements in optimizing cell-based therapies for various cancers. The theme of the research presented by the 4 groups was the increasing specificity with which therapies are able to target cancer cells and the current problems with broad solutions such as chemotherapy and radiation. 

It's free! Log in now to read

LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top